| scholarly article | Q13442814 |
| P2093 | author name string | A M Bowcock | |
| H M Lederman | |||
| C Helms | |||
| N Ho | |||
| T A Chatila | |||
| C Voulgaropoulos | |||
| F Blaeser | |||
| P2860 | cites work | An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains | Q24313206 |
| X-Linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3. | Q24539046 | ||
| Positional cloning of the APECED gene | Q28116470 | ||
| Human N-myc is closely related in organization and nucleotide sequence to c-myc | Q28299447 | ||
| Disease in the scurfy (sf) mouse is associated with overexpression of cytokine genes | Q28509666 | ||
| CD4+CD8- T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse | Q28510215 | ||
| Cellular and molecular characterization of the scurfy mouse mutant | Q28513849 | ||
| Winged helix proteins | Q29617630 | ||
| Manifestations and linkage analysis in X-linked autoimmunity-immunodeficiency syndrome | Q30305447 | ||
| An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome | Q33328425 | ||
| The scurfy mouse mutant has previously unrecognized hematological abnormalities and resembles Wiskott-Aldrich syndrome | Q33404650 | ||
| Lineage commitment in the immune system: the T helper lymphocyte grows up. | Q33970744 | ||
| Five years on the wings of fork head | Q34398426 | ||
| X-linked lymphoreticular disease in the scurfy (sf) mutant mouse | Q35831357 | ||
| Transplantation of T cell-mediated, lymphoreticular disease from the scurfy (sf) mouse. | Q35834004 | ||
| The absence of the transcription activator TFE3 impairs activation of B cells in vivo | Q36568776 | ||
| X-linked immune dysregulation, neonatal insulin dependent diabetes, and intractable diarrhoea | Q36859835 | ||
| Neonatal diabetes mellitus associated with severe diarrhea, hyperimmunoglobulin E syndrome, and absence of islets of Langerhans | Q40968072 | ||
| The N-Myc oncoprotein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells | Q41083303 | ||
| X linked immune dysregulation, neonatal insulin dependent diabetes, and intractable diarrhoea | Q42100569 | ||
| A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients | Q47852328 | ||
| An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. | Q55062928 | ||
| Complement deficiencies | Q68132805 | ||
| DNA binding by N- and L-Myc proteins | Q70618265 | ||
| A Japanese family of X-linked auto-immune enteropathy with haemolytic anaemia and polyendocrinopathy | Q70680709 | ||
| The mouse scurfy (sf) mutation is tightly linked to Gata1 and Tfe3 on the proximal X chromosome | Q72529315 | ||
| Congenital autoimmune diabetes mellitus | Q73810945 | ||
| A transcript map of a 2-Mb BAC contig in the proximal portion of the mouse X chromosome and regional mapping of the scurfy mutation | Q73904563 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | R75-81 | |
| P577 | publication date | 2000-12-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome | |
| P478 | volume | 106 |
| Q41648555 | A 33D1+ Dendritic Cell/Autoreactive CD4+ T Cell Circuit Maintains IL-2-Dependent Regulatory T Cells in the Spleen |
| Q64079625 | A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy |
| Q34243359 | A critical role for regulatory T cell-mediated control of inflammation in the absence of commensal microbiota |
| Q52140917 | A fork in the road to fertility. |
| Q34197513 | A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes |
| Q30419044 | A novel function of IL-2: chemokine/chemoattractant/retention receptor genes induction in Th subsets for skin and lung inflammation |
| Q45183631 | A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders |
| Q53563995 | A potential screening tool for IPEX syndrome. |
| Q34634834 | A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy. |
| Q24622687 | A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity |
| Q36078042 | A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. |
| Q33476832 | Absence of leucine zipper in the natural FOXP3Delta2Delta7 isoform does not affect dimerization but abrogates suppressive capacity. |
| Q36002606 | Activation of naturally occurring lung CD4(+)CD25(+) regulatory T cells requires CD8 and MHC I interaction |
| Q33539782 | Adaptive autoimmunity and Foxp3-based immunoregulation in zebrafish |
| Q33639952 | Affinity-based selection of regulatory T cells occurs independent of agonist-mediated induction of Foxp3 expression |
| Q34548646 | Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy |
| Q24293865 | Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice |
| Q41915075 | Altered sympathetic-to-immune cell signaling via β₂-adrenergic receptors in adjuvant arthritis. |
| Q47126679 | Alternative Polyadenylation in Human Diseases. |
| Q29618395 | An essential role for Scurfin in CD4+CD25+ T regulatory cells |
| Q36016613 | An in vivo IL-7 requirement for peripheral Foxp3+ regulatory T cell homeostasis |
| Q54608720 | An inverse correlation of human peripheral blood regulatory T cell frequency with the disease activity of ulcerative colitis. |
| Q80059469 | Analysis of CD4+ CD25+ regulatory T cells and Foxp3 mRNA in the peripheral blood of patients with asthma |
| Q60311694 | Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level |
| Q24300325 | Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor |
| Q48155143 | Antigen-specific Treg cells in immunological tolerance: implications for allergic diseases. |
| Q34979858 | Artemisinin analogue SM934 ameliorates murine experimental autoimmune encephalomyelitis through enhancing the expansion and functions of regulatory T cell |
| Q24649522 | Assessing the impact of FOXP1 mutations on developmental verbal dyspraxia |
| Q47220145 | Atypical Late-Onset Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome with Intractable Diarrhea: A Case Report |
| Q56897543 | Beta2-adrenergic receptor signaling in CD4+ Foxp3+ regulatory T cells enhances their suppressive function in a PKA-dependent manner |
| Q33855051 | CARMA1 regulation of regulatory T cell development involves modulation of interleukin-2 receptor signaling |
| Q36013875 | CD25+ T cells and regulation of allergen-induced responses |
| Q34813153 | CD4 T cells: fates, functions, and faults |
| Q41872888 | CD4(+)CD25(hi)Foxp3(+) Cells Exacerbate Bleomycin-Induced Pulmonary Fibrosis |
| Q92538754 | CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation |
| Q35080651 | CD8 regulates T regulatory cell production of IL-6 and maintains their suppressive phenotype in allergic lung disease |
| Q37869488 | Cell therapy to promote transplantation tolerance: a winning strategy? |
| Q36015241 | Cell-autonomous role of TGFβ and IL-2 receptors in CD4+ and CD8+ inducible regulatory T-cell generation during GVHD. |
| Q26853475 | Cellular and molecular determinants for the development of natural and induced regulatory T cells |
| Q37046632 | Cellular aspects of atopic dermatitis. |
| Q34004612 | Cellular therapies supplement: the role of granulocyte macrophage colony-stimulating factor and dendritic cells in regulatory T-cell homeostasis and expansion |
| Q84483323 | Central tolerance: essential for preventing autoimmune disease? |
| Q42945138 | Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells—Identification of Foxp3Δ7 in human regulatory T cells |
| Q37657051 | Checkpoints in lymphocyte development and autoimmune disease |
| Q37486824 | Chronic follicular bronchiolitis requires antigen-specific regulatory T cell control to prevent fatal disease progression |
| Q58615948 | Clinical Heterogeneity of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A French Multicenter Retrospective Study |
| Q54372229 | Clinical and molecular characteristics of immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in China. |
| Q36153699 | Clinical and molecular findings in IPEX syndrome |
| Q37301616 | Clinical efficacy and immune regulation with peanut oral immunotherapy |
| Q37022929 | Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes |
| Q46321148 | Clinical heterogeneity of immunodysregulation, polyendocrinopathy, enteropathy, X-linked: pulmonary involvement as a non-classical disease manifestation |
| Q37095214 | Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes |
| Q59137718 | Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome |
| Q36403785 | Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia |
| Q35817877 | Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions |
| Q51815077 | Comparison of stable human Treg and Th clones by transcriptional profiling. |
| Q28273769 | Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor |
| Q34658594 | Control of regulatory T cell lineage commitment and maintenance |
| Q24306205 | Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells |
| Q27003993 | Current aspects of vitiligo genetics |
| Q36857703 | Cutting edge: Broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells |
| Q40065888 | Cytokine-Mediated Regulation of Human Lymphocyte Development and Function: Insights from Primary Immunodeficiencies. |
| Q36756168 | Cytopenia and autoimmune diseases: a vicious cycle fueled by mTOR dysregulation in hematopoietic stem cells. |
| Q50521304 | Cytotoxic T lymphocyte antigen 4 immunoglobulin modified dendritic cells attenuate allergic airway inflammation and hyperresponsiveness by regulating the development of T helper type 1 (Th1)/Th2 and Th2/regulatory T cell subsets in a murine model of |
| Q35098075 | DNA binding by FOXP3 domain-swapped dimer suggests mechanisms of long-range chromosomal interactions. |
| Q47618099 | DOCK8 Deficiency Presenting as an IPEX-Like Disorder. |
| Q40593900 | Defective natural killer cell activity in a mouse model of eczema herpeticum |
| Q56901192 | Deficient SOCS3 expression in CD4+CD25+FoxP3+ regulatory T cells and SOCS3-mediated suppression of Treg function |
| Q41697162 | Dermatophagoides pteronyssinus immunotherapy changes the T-regulatory cell activity. |
| Q45864086 | Designer lymphocytes to fight cancer: a helping hand from modern molecular biology |
| Q35992122 | Development and maintenance of intestinal regulatory T cells |
| Q34596070 | Dicer-dependent microRNA pathway safeguards regulatory T cell function |
| Q39064897 | Differential coexpression of FoxP1, FoxP2, and FoxP4 in the Zebra Finch (Taeniopygia guttata) song system |
| Q46974888 | Dihydrotestosterone levels at birth associate positively with higher proportions of circulating immature/naïve CD5+ B cells in boys |
| Q34778974 | Dissecting the role of the FOXP3 gene in the joint genetic susceptibility to autoimmune thyroiditis and diabetes: a genetic and functional analysis |
| Q44914986 | Dynamic regulation of FoxP3 expression controls the balance between CD4+ T cell activation and cell death |
| Q46844016 | Elevated T regulatory cells in long-term stable transplant tolerance in rhesus macaques induced by anti-CD3 immunotoxin and deoxyspergualin |
| Q38973059 | Elevated receptor for activated C kinase 1 expression is involved in intracellular Ca2+ influx and potentially associated with compromised regulatory T cell function in patients with asthma |
| Q36010560 | Escape from tolerance in the human X-linked autoimmunity-allergic disregulation syndrome and the Scurfy mouse |
| Q34778685 | Exome sequencing identifies a novel FOXP3 mutation in a 2-generation family with inflammatory bowel disease |
| Q56898769 | Experimentally induced accumulation of Foxp3⁺ T cells in upper airway allergy |
| Q33949282 | Extra-thymically induced regulatory T cells: do they have potential in disease prevention? |
| Q28728365 | Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict |
| Q90610367 | FOXF2 is required for cochlear development in humans and mice |
| Q36871999 | FOXP1: a potential therapeutic target in cancer. |
| Q90245662 | FOXP3 Activates SUMO-Conjugating UBC9 Gene in MCF7 Breast Cancer Cells |
| Q37216338 | FOXP3 and its partners: structural and biochemical insights into the regulation of FOXP3 activity |
| Q38203784 | FOXP3 and scurfy: how it all began |
| Q35845395 | FOXP3 as an X-linked tumor suppressor |
| Q24299602 | FOXP3 ensembles in T-cell regulation |
| Q36138019 | FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2. |
| Q35987520 | FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene |
| Q48201259 | FOXP3 mutations causing early-onset insulin-requiring diabetes but without other features of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. |
| Q35624706 | FOXP3 orchestrates H4K16 acetylation and H3K4 trimethylation for activation of multiple genes by recruiting MOF and causing displacement of PLU-1. |
| Q26781235 | FOXP3(+) Treg Cells and Gender Bias in Autoimmune Diseases |
| Q36628377 | FOXP3+ regulatory T cells: Current controversies and future perspectives |
| Q46056303 | FOXP3, the Transcription Factor at the Heart of the Rebirth of Immune Tolerance |
| Q27003398 | FOXP3: genetic and epigenetic implications for autoimmunity |
| Q37634024 | Fetal regulatory T cells and peripheral immune tolerance in utero: implications for development and disease |
| Q53951581 | Few Foxp3⁺ regulatory T cells are sufficient to protect adult mice from lethal autoimmunity. |
| Q38124117 | Forkhead Box P family members at the crossroad between tolerance and immunity: a balancing act. |
| Q38172563 | Forkhead box P3: the peacekeeper of the immune system. |
| Q51016364 | Forkhead box protein 3 demethylation is associated with tolerance induction in peanut-induced intestinal allergy. |
| Q42655696 | Forkhead-Box-P3 Gene Transfer in Human CD4+ T Conventional Cells for the Generation of Stable and Efficient Regulatory T Cells, Suitable for Immune Modulatory Therapy |
| Q35934174 | Forkhead-box transcription factors and their role in the immune system |
| Q92447186 | FoxP3 in Treg cell biology: a molecular and structural perspective |
| Q37804609 | FoxP3+ CD4+ T cells in systemic autoimmune diseases: the delicate balance between true regulatory T cells and effector Th-17 cells |
| Q37009831 | FoxP3: a life beyond regulatory T cells |
| Q43239269 | Foxp3 and dominant tolerance |
| Q35204514 | Foxp3 and natural regulatory T cells: key to a cell lineage? |
| Q38234076 | Foxp3 expression in T regulatory cells and other cell lineages |
| Q36794299 | Foxp3 in control of the regulatory T cell lineage |
| Q24298812 | Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells |
| Q27860714 | Foxp3 programs the development and function of CD4+CD25+ regulatory T cells |
| Q40509547 | Foxp3(+) regulatory T cells in mouse models of type 1 diabetes |
| Q50962900 | Foxp3+ cells control Th2 responses in a murine model of atopic dermatitis. |
| Q35172468 | Foxp3⁺ regulatory T cells exert asymmetric control over murine helper responses by inducing Th2 cell apoptosis. |
| Q52848497 | Frequency of Treg cells is reduced in CVID patients with autoimmunity and splenomegaly and is associated with expanded CD21lo B lymphocytes. |
| Q34515848 | From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation |
| Q28591913 | Functional characterization of rare FOXP2 variants in neurodevelopmental disorder |
| Q35740840 | Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis |
| Q92432963 | Functional reprogramming of regulatory T cells in the absence of Foxp3 |
| Q93238177 | GM-CSF therapy inhibits chronic graft-versus-host disease via expansion of regulatory T cells |
| Q43135547 | GP96 is a GARP chaperone and controls regulatory T cell functions. |
| Q34607035 | GRAIL is up-regulated in CD4+ CD25+ T regulatory cells and is sufficient for conversion of T cells to a regulatory phenotype |
| Q35646681 | Gene/cell therapy approaches for Immune Dysregulation Polyendocrinopathy Enteropathy X-linked syndrome. |
| Q36938160 | Generation and function of induced regulatory T cells |
| Q35004067 | Generation of Regulatory T Cells to Antigen Expressed in the Retina. |
| Q36816687 | Genes mediating environment interactions in type 1 diabetes |
| Q64074640 | Genetic Mechanisms Highlight Shared Pathways for the Pathogenesis of Polygenic Type 1 Diabetes and Monogenic Autoimmune Diabetes |
| Q51738569 | Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. |
| Q28080809 | Graft versus host disease: New insights into A2A receptor agonist therapy |
| Q24802813 | HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells |
| Q46681395 | HLA DRB1*1503 allelic haplotype predominance and associated immunodysregulation in systemic lupus erythematosus |
| Q92342000 | Helper T cell differentiation |
| Q46625451 | Heterogeneity of type 1 diabetes mellitus |
| Q101039014 | Heterozygous variants that disturb the transcriptional repressor activity of FOXP4 cause a developmental disorder with speech/language delays and multiple congenital abnormalities |
| Q42969634 | High proportions of FOXP3(+) CD25(high) T cells in neonates are positively associated with allergic sensitization later in childhood |
| Q35609361 | Higher proportions of circulating FOXP3+ and CTLA-4+ regulatory T cells are associated with lower fractions of memory CD4+ T cells in infants |
| Q37792465 | Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function |
| Q26995345 | Homeostasis and function of regulatory T cells in HIV/SIV infection |
| Q37596517 | How do regulatory T cells work? |
| Q35962333 | Human Embryonic Stem Cell Lines with Lesions in FOXP3 and NF1. |
| Q37405703 | Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function |
| Q30309445 | Human genome search in celiac disease: mutated gliadin T-cell-like epitope in two human proteins promotes T-cell activation |
| Q40295638 | Humoral Immunodeficiency with Hypotonia, Feeding Difficulties, Enteropathy, and Mild Eczema Caused by a Classical FOXP3 Mutation |
| Q35615786 | IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin |
| Q41036719 | IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function. |
| Q87058156 | IPEX Syndrome, FOXP3 and Cancer |
| Q42133967 | IPEX and the role of Foxp3 in the development and function of human Tregs |
| Q34583514 | IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. |
| Q28592846 | Identification of chromatin remodeling genes Arid4a and Arid4b as leukemia suppressor genes |
| Q56795456 | Identification of sex-specific DNA methylation changes driven by specific chemicals in cord blood in a Faroese birth cohort |
| Q33936032 | Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter |
| Q49851572 | Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells |
| Q37106307 | Immune deficiency disorders with autoimmunity and abnormalities in immune regulation-monogenic autoimmune diseases |
| Q33718865 | Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases. |
| Q36282394 | Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity |
| Q35050810 | Immune profiling and cancer post transplantation |
| Q26851623 | Immune regulation by histone deacetylases: a focus on the alteration of FOXP3 activity |
| Q36472057 | Immunodeficiencies with autoimmune consequences. |
| Q36616792 | Immunodeficiency in childhood |
| Q36236762 | Immunogenetics of autoimmune thyroid diseases: A comprehensive review |
| Q34007974 | Immunoglobulin E signal inhibition during allergen ingestion leads to reversal of established food allergy and induction of regulatory T cells |
| Q38028369 | Immunological mechanisms for desensitization and tolerance in food allergy |
| Q34001083 | Immunological tolerance and autoimmunity |
| Q36273406 | Immunotherapy of hypersensitivity to hymenoptera venom |
| Q51727790 | Immunotherapy with iTreg and nTreg Cells in a Murine Model of Inflammatory Bowel Disease. |
| Q35581731 | Immunotherapy with mycobacteria |
| Q36002814 | Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome |
| Q36189648 | Implications of polyadenylation in health and disease |
| Q96131145 | In situ conversion of defective Treg into SuperTreg cells to treat advanced IPEX-like disorders in mice |
| Q34548023 | In vivo instruction of suppressor commitment in naive T cells |
| Q33282703 | Inability to mediate prolonged reduction of regulatory T Cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapy |
| Q35206452 | Inactivation of X-linked tumor suppressor genes in human cancer |
| Q35363011 | Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers |
| Q45158781 | Induction of ALDH activity in intestinal dendritic cells by Lactobacillus plantarum NRIC0380. |
| Q46061458 | Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity |
| Q36176645 | Induction of transplantation tolerance-the potential of regulatory T cells |
| Q36608555 | Infiltrating regulatory T cell numbers is not a factor to predict patient's survival in oesophageal squamous cell carcinoma |
| Q36688093 | Inhaled corticosteroid use is associated with increased circulating T regulatory cells in children with asthma |
| Q38213044 | Insulin gene mutations and diabetes |
| Q36561222 | Interleukin-10-secreting regulatory T cells in allergy and asthma |
| Q34269144 | Interleukin-7 influences FOXP3+CD4+ regulatory T cells peripheral homeostasis |
| Q42846660 | Isolation and expansion of human natural T regulatory cells for cellular therapy |
| Q37375680 | Kruppel-like factor KLF10 targets transforming growth factor-beta1 to regulate CD4(+)CD25(-) T cells and T regulatory cells |
| Q36267143 | Lack of Foxp3 function and expression in the thymic epithelium |
| Q40348808 | Late-onset of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome (IPEX) with intractable diarrhea. |
| Q36057563 | Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer. |
| Q41677301 | Liver X receptor activation promotes differentiation of regulatory T cells |
| Q33919580 | MeCP2 enforces Foxp3 expression to promote regulatory T cells' resilience to inflammation |
| Q26866369 | Mechanism of oral tolerance induction to therapeutic proteins |
| Q59271653 | Mechanisms of allergen-specific immunotherapy |
| Q39402881 | Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells. |
| Q36429815 | Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells |
| Q37509047 | Mechanisms of tolerance and allergic sensitization in the airways and the lungs. |
| Q63343212 | Medium-term survival without haematopoietic stem cell transplantation in a case of IPEX: insights into nutritional and immunosuppressive therapy |
| Q40065267 | Metabolism in Immune Cell Differentiation and Function. |
| Q38198412 | Microbial and dietary factors modulating intestinal regulatory T cell homeostasis |
| Q36187451 | Modification of dendritic cell function as a tool to prevent and treat allergic asthma |
| Q34674882 | Modification of the FoxP3 transcription factor principally affects inducible T regulatory cells in a model of experimental autoimmune encephalomyelitis |
| Q50671091 | Molecular Mechanisms of Regulatory T Cell Development and Suppressive Function |
| Q36456864 | Molecular and biological role of the FOXP3 N-terminal domain in immune regulation by T regulatory/suppressor cells |
| Q46558096 | Molecular mechanisms of regulatory T cell development. |
| Q36905445 | Molecular mechanisms regulating TGF-beta-induced Foxp3 expression |
| Q37390979 | Molecular orchestration of differentiation and function of regulatory T cells |
| Q82975296 | Monoclonal antibodies raised to the human FOXP3 protein can be used effectively for detecting Foxp3(+) T cells in other mammalian species |
| Q38913100 | Monogenic autoimmune diseases of the endocrine system |
| Q37973770 | Monogenic autoimmunity |
| Q33965424 | Multiple Domains Define the Expression and Regulatory Properties of Foxp1 Forkhead Transcriptional Repressors |
| Q36194882 | Mutations in the Kir6.2 subunit of the KATP channel and permanent neonatal diabetes: new insights and new treatment |
| Q35913635 | MyD88 is critically involved in immune tolerance breakdown at environmental interfaces of Foxp3-deficient mice |
| Q51765584 | Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. |
| Q36423940 | Natural regulatory T cells and persistent viral infection |
| Q29619194 | Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self |
| Q37299722 | Naturally occurring and inducible T-regulatory cells modulating immune response in allergic asthma |
| Q33322892 | Negative feedback regulation of T cells via interleukin-2 and FOXP3 reciprocity |
| Q81152665 | Neonatal diabetes mellitus |
| Q34715346 | Neonatal syndromes of polyendocrinopathy |
| Q52719679 | Neutralizing Anti-Cytokine Autoantibodies Against Interferon-α in Immunodysregulation Polyendocrinopathy Enteropathy X-Linked. |
| Q44808755 | New autoimmune genes and the pathogenesis of type 1 diabetes |
| Q35078468 | New insights into the genetics of neonatal diabetes |
| Q81761281 | New tools to identify regulatory T cells |
| Q34477650 | OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity |
| Q28609463 | PIP3 pathway in regulatory T cells and autoimmunity |
| Q39312947 | PTD-hFOXP3 protein acts as an immune regulator to convert human CD4(+)CD25(-) T cells to regulatory T-like cells |
| Q34778734 | Pathogen-sensing and regulatory T cells: integrated regulators of immune responses |
| Q37748077 | Pathogenic mechanisms of allergic inflammation: atopic asthma as a paradigm |
| Q41789781 | Patients with posttraumatic stress disorder exhibit an altered phenotype of regulatory T cells |
| Q30278478 | Patterns of Allergic Sensitization in High IgE Syndromes |
| Q38849738 | Pediatric inflammatory bowel disease: specificity of very early onset |
| Q35953106 | Pim-2 Kinase Influences Regulatory T Cell Function and Stability by Mediating Foxp3 Protein N-terminal Phosphorylation |
| Q38086869 | Potential of targeting TGF-β for organ transplant patients |
| Q36073821 | Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. |
| Q42242575 | Prevalence of Foxp3 positive T regulatory cells is increased during progression of cutaneous squamous tumors |
| Q52651330 | Primary atopic disorders. |
| Q40638236 | Primary immunodeficiency diseases: dissectors of the immune system |
| Q36971211 | Prognostic markers and gene abnormalities in subgroups of diffuse large B-cell lymphoma: single center experience |
| Q39704696 | Proximal human FOXP3 promoter transactivated by NF-kappaB and negatively controlled by feedback loop and SP3. |
| Q52729197 | RORα-expressing T regulatory cells restrain allergic skin inflammation. |
| Q38119863 | Recent advances in transplantation for primary immune deficiency diseases: a comprehensive review |
| Q37792762 | Recognizing Gastrointestinal and Hepatic Manifestations of Primary Immunodeficiency Diseases |
| Q37248276 | Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity |
| Q36148406 | Regulation of immunity by self-reactive T cells |
| Q91591099 | Regulation of regulatory T cells in cancer |
| Q58556230 | Regulation of the Germinal Center Response |
| Q33860019 | Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6 |
| Q30276673 | Regulatory T Cells Control Th2-Dominant Murine Autoimmune Gastritis |
| Q38948512 | Regulatory T Cells and Cancer: A Two-Sided Story |
| Q33715605 | Regulatory T Cells in Allergy and Asthma. |
| Q38927531 | Regulatory T Cells: Central Concepts from Ontogeny to Therapy |
| Q37510514 | Regulatory T cell ablation causes acute T cell lymphopenia |
| Q44440268 | Regulatory T cell development in the absence of functional Foxp3. |
| Q35196374 | Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy |
| Q36388773 | Regulatory T cell-mediated transplantation tolerance |
| Q36986732 | Regulatory T cells - a brief history and perspective |
| Q34177949 | Regulatory T cells and Foxp3 |
| Q36332180 | Regulatory T cells and IL-10 in allergic inflammation |
| Q38233294 | Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β. |
| Q34789108 | Regulatory T cells and immune tolerance in the intestine |
| Q37929548 | Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome. |
| Q38946820 | Regulatory T cells in allergic diseases. |
| Q36064548 | Regulatory T cells in asthma |
| Q84073243 | Regulatory T cells in cancer |
| Q36562855 | Regulatory T cells in human autoimmune diseases |
| Q36203567 | Regulatory T cells in immunologic self-tolerance and autoimmune disease |
| Q36419022 | Regulatory T cells in lupus |
| Q37349918 | Regulatory T cells in renal disease |
| Q82076756 | Regulatory T cells in rheumatoid arthritis |
| Q29622850 | Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice |
| Q36911411 | Regulatory T cells--the renaissance of the suppressor T cells. |
| Q37236796 | Regulatory T cells: key players in tolerance and autoimmunity. |
| Q29620731 | Regulatory T cells: mechanisms of differentiation and function |
| Q37897263 | Regulatory T helper cells in pregnancy and their roles in systemic versus local immune tolerance |
| Q35384216 | Regulatory T-cell Trafficking: From Thymic Development to Tumor-Induced Immune Suppression |
| Q37981846 | Regulatory T-cell abnormalities and the global epidemic of immuno-inflammatory disease |
| Q34892704 | Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA. |
| Q59564528 | Regulatory T-cell function: When suppressor cells can't suppress |
| Q38003474 | Regulatory cells in allergen-specific immunotherapy |
| Q37140284 | Regulatory immune cells in kidney disease |
| Q38441691 | Renal involvement in the immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) disorder |
| Q34743118 | Requirements for growth and IL-10 expression of highly purified human T regulatory cells |
| Q35044185 | Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts |
| Q45863745 | Rescue of the autoimmune scurfy mouse by partial bone marrow transplantation or by injection with T-enriched splenocytes |
| Q41037936 | Respiratory syncytial virus nonstructural proteins 1 and 2 are crucial pathogenic factors that modulate interferon signaling and Treg cell distribution in mice. |
| Q37690644 | Role of Treg in immune regulation of allergic diseases. |
| Q38497370 | Role of regulatory T cells in rheumatoid arthritis: facts and hypothesis. |
| Q49956370 | Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases |
| Q37076055 | STAT6 controls the number of regulatory T cells in vivo, thereby regulating allergic lung inflammation |
| Q24291515 | Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation |
| Q64093120 | Scurfy Mice Develop Features of Connective Tissue Disease Overlap Syndrome and Mixed Connective Tissue Disease in the Absence of Regulatory T Cells |
| Q38172210 | Searching for the Achilles Heel of FOXP3 |
| Q28359868 | Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs |
| Q85574504 | Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with Alopecia areata |
| Q34597933 | Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development |
| Q37378517 | Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate |
| Q79147744 | Splice variants of human FOXP3 are functional inhibitors of human CD4+ T-cell activation |
| Q41968549 | Staphylococcus aureus convert neonatal conventional CD4(+) T cells into FOXP3(+) CD25(+) CD127(low) T cells via the PD-1/PD-L1 axis. |
| Q27670827 | Structural and Biological Features of FOXP3 Dimerization Relevant to Regulatory T Cell Function |
| Q24300742 | Structure of the forkhead domain of FOXP2 bound to DNA |
| Q33758029 | Suppression of IL-12p70 formation by IL-2 or following macrophage depletion causes T-cell autoreactivity leading to CNS demyelination in HSV-1-infected mice. |
| Q52094356 | Survey of forkhead domain encoding genes in the Drosophila genome: Classification and embryonic expression patterns. |
| Q92511099 | Systemic silencing of PHD2 causes reversible immune regulatory dysfunction |
| Q93109740 | T cell anergy in perinatal mice is promoted by T reg cells and prevented by IL-33 |
| Q51976612 | T cells stimulated in vitro have a suppressive function but do not contain only regulatory T cells. |
| Q36327399 | T regulatory cells in allergen-specific immunotherapy. |
| Q53331257 | T regulatory cells lacking CD25 are increased in MS during relapse. |
| Q41966454 | T regulatory cells play a significant role in modulating MHC class I antibody-induced obliterative airway disease. |
| Q35459820 | T regulatory cells: aid or hindrance in the clearance of disease? |
| Q26862699 | T-regulatory cells in primary immune deficiencies |
| Q37377465 | TCR-dependent differentiation of thymic Foxp3+ cells is limited to small clonal sizes |
| Q36685552 | TH2 cells in the pathogenesis of airway remodeling: regulatory T cells a plausible panacea for asthma |
| Q38985243 | TREG Cells in Cancer: Beyond Classical Immunological Control |
| Q36232715 | Target identification and validation in systemic autoimmunity |
| Q37088207 | Targeted antigen delivery to DEC-205⁺ dendritic cells for tolerogenic vaccination |
| Q38071254 | Targeting the "cytokine storm" for therapeutic benefit |
| Q35769460 | Th2 cells: orchestrating barrier immunity |
| Q36992773 | The Critical Role of TGF-beta1 in the Development of Induced Foxp3+ Regulatory T Cells |
| Q47755372 | The Dual Role of Treg in Cancer |
| Q50133998 | The Gut Microbiome and Multiple Sclerosis. |
| Q39385246 | The IL-10/STAT3 axis: Contributions to immune tolerance by thymus and peripherally derived regulatory T-cells |
| Q40049468 | The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice |
| Q28069781 | The Immunomodulatory Functions of Diacylglycerol Kinase ζ |
| Q37055921 | The Role of Skin Barrier in the Pathogenesis of Food Allergy |
| Q36162564 | The STAT5b Pathway Defect and Autoimmunity |
| Q28505508 | The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis |
| Q37393703 | The T(reg)/Th17 cell balance: a new paradigm for autoimmunity |
| Q33863995 | The Vitamin D Antenatal Asthma Reduction Trial (VDAART): rationale, design, and methods of a randomized, controlled trial of vitamin D supplementation in pregnancy for the primary prevention of asthma and allergies in children. |
| Q35962634 | The battle against immunopathology: infectious tolerance mediated by regulatory T cells |
| Q37228646 | The biology and therapeutic potential of natural regulatory T-cells in the bone marrow transplant setting |
| Q37728840 | The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease |
| Q36218421 | The development and function of memory regulatory T cells after acute viral infections |
| Q36634562 | The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study. |
| Q28751831 | The evolution of Fox genes and their role in development and disease |
| Q60917471 | The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis |
| Q37190733 | The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis? |
| Q28510411 | The mutant leucine-zipper domain impairs both dimerization and suppressive function of Foxp3 in T cells |
| Q40008903 | The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery |
| Q90124443 | The presentation of neuroendocrine self-peptides in the thymus: an essential event for individual life and vertebrate survival |
| Q35931795 | The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cells |
| Q90329887 | The relationship between TIGIT+ regulatory T cells and autoimmune disease |
| Q37767175 | The relationship of x-linked primary immune deficiencies and autoimmunity |
| Q38029556 | The role of FOXP3 in the development and metastatic spread of breast cancer. |
| Q36747499 | The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease |
| Q36752196 | The role of natural regulatory T cells in infection |
| Q35685189 | The role of regulatory T cells in allergy |
| Q30371308 | The role of regulatory T cells in atopic dermatitis. |
| Q34441735 | The role of the FOXP3 transcription factor in the immune regulation of allergic asthma. |
| Q37803117 | The roles of c‐rel and interleukin‐2 in tolerance: a molecular explanation of self–nonself discrimination |
| Q47105632 | The transcription factor Batf3 inhibits the differentiation of regulatory T cells in the periphery. |
| Q52674851 | Therapeutic Potential of Gene-Modified Regulatory T Cells: From Bench to Bedside. |
| Q33684806 | Therapeutic potential of TGF-β-induced CD4(+) Foxp3(+) regulatory T cells in autoimmune diseases. |
| Q90737847 | Therapeutic potential of aryl hydrocarbon receptor in autoimmunity |
| Q47761658 | Therapeutic targeting of FOXP3-positive regulatory T cells using a FOXP3 peptide vaccine WO2008081581. |
| Q37636838 | Thymic Nurse Cells Participate in Heterotypic Internalization and Repertoire Selection of Immature Thymocytes; Their Removal from the Thymus of Autoimmune Animals May be Important to Disease Etiology |
| Q36959215 | Thymic versus induced regulatory T cells - who regulates the regulators? |
| Q24603791 | Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions |
| Q38135555 | Transcriptional control of regulatory T cell development and function |
| Q58234949 | Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells |
| Q26772335 | Translating Treg Therapy in Humanized Mice |
| Q37632479 | Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. |
| Q34602052 | Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders |
| Q36192911 | Treg cells, life history, and diversity |
| Q56987489 | Twenty-first century Foxp3 |
| Q93388177 | Two male siblings with a novel LRBA mutation presenting with different findings of IPEX syndrome |
| Q37378417 | Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance |
| Q37571619 | X chromosome inactivation and autoimmunity |
| Q37039682 | X chromosome inactivation and female predisposition to autoimmunity |
| Q24681000 | X-chromosome inactivation analysis in a female carrier of FOXP3 mutation |
| Q35850633 | X-linked immunodeficiencies |
| Q33980087 | X-linked tumor suppressors: perplexing inheritance, a unique therapeutic opportunity. |
| Q61647760 | Zeroing in on tolerance |
| Q45771316 | p27(Kip1) inhibits systemic autoimmunity through the control of Treg cell activity and differentiation |
Search more.